Mint ACE Pump
Beta Bionics, Inc. · Decision date Oct 21, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for the Mint ACE Pump, submitted by Beta Bionics, Inc. of Irvine, California, under 510(k) number K263422. The agency lists the device classification as Alternate Controller Enabled Insulin Infusion Pump, regulation number 880.5730, product code QFG, with a Clinical Chemistry review panel. The application was received on 09/25/2026 and decided on 10/21/2026. A SESE finding is a 510(k) clearance, not a premarket approval of a new device.
The public record identifies the submission as a Special-type 510(k) that was not reviewed by a third party, not a combination product, and without an authorized Predetermined Change Control Plan. The listed applicant contact and correspondent contact are the same. The available material does not describe the specific device components, the predicate device, or the basis for the equivalence determination; those details would sit in the underlying 510(k) summary and review documents, which are not included here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Clinical Chemistry
- Decision date
- Oct 21, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K263422
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Beta Bionics, Inc.
- Product code
- QFG
- Decision code
- SESE
- Decision date
- Oct 21, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Alternate Controller Enabled Insulin Infusion Pump.
- Applicant
- Beta Bionics, Inc.
- Product code
- QFG
- FDA device class
- 2
FDA decision timeline
K263422 received
Application receipt date recorded by FDA.
K263422 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code QFG
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Mint ACE PumpK260001 | Beta Bionics, Inc. | 510(k) clearance | Sep 11, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Beta Bionics, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Irvine, CA
Sources and methodology
- Original FDA record: K263422
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records